China National Medicines Corporation Ltd.’s Net Profit Rose 31.4% in First Three Quarters of 2021

China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (600511.SH) reported a net profit of 1.4 billion yuan in the first three quarters of 2021, up 31.4% year-on-year.

Meanwhile, the company posted 34.3 billion yuan in revenue, up 17.8% year-on-year.

At the end of the reporting period, it had 27.5 billion yuan in total assets and 13.7 billion yuan in total liabilities, with a liability-to-asset ratio of 49.7%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.